Identifying new clotting factor XIa inhibitors in virtual high-throughput screens using PCA-GA-SVM models and signature

Biotechnology Progress
Jonathan J ChenDonald P Visco

Abstract

Blood Clotting Factor XI is an important actor in the clotting mechanism: it activates downstream zymogen involved in the clotting process. It can be targeted for activation or inhibition depending on treatment goals to enhance or inhibit clotting. In terms of antithrombosis treatment, Factor XI has emerged as a promising target to focus on. In this work, an iterative virtual high-throughput screening pipeline was proposed that can supplement current efforts to find inhibitors. The first iteration identified 11 compounds to test with 3 active for a hit-rate of 27.3%. The second iteration of the pipeline identified another 11 compounds to test with 7 active for a hit-rate of 63.6%. © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 34:1553-1565, 2018.

References

Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H SaitoN Aoki
Sep 2, 1991·Science·D Gailani, G J Broze
Nov 17, 1987·Biochemistry·R AsakaiD W Chung
Feb 1, 1986·The Journal of Clinical Investigation·C F ScottR W Colman
Dec 7, 1973·Nature·P S DamusR D Rosenberg
Jan 1, 1996·Medicinal Research Reviews·R S BohacekW C Guida
Mar 9, 2000·The New England Journal of Medicine·J C MeijersF R Rosendaal
Mar 17, 2000·Science·J Drews
Sep 12, 2000·Haemophilia : the Official Journal of the World Federation of Hemophilia·P H Bolton-Maggs
Jun 20, 2002·Journal of Molecular Graphics & Modelling·Donald P ViscoJean-Loup Faulon
Jul 27, 2002·Annual Review of Pharmacology and Toxicology·Chung F Wong, J Andrew McCammon
Nov 26, 2002·Journal of Chemical Information and Computer Sciences·Xin Chen, Charles H Reynolds
May 28, 2003·Journal of Chemical Information and Computer Sciences·Jean-Loup FaulonRamdas S Pophale
May 28, 2003·Journal of Chemical Information and Computer Sciences·Jean-Loup FaulonDonald P Visco
Jan 1, 1953·Proceedings of the Society for Experimental Biology and Medicine·R L ROSENTHALN ROSENTHAL
Sep 18, 1964·Science·E W DAVIE, O D RATNOFF
Apr 30, 2004·Journal of Computational Chemistry·Junmei WangDavid A Case
Jun 5, 2004·Journal of Molecular Graphics & Modelling·Carla J ChurchwellJean-Loup Faulon
Aug 21, 2004·Bioinformatics·Shawn MartinJean-Loup Faulon
Sep 28, 2004·Journal of Chemical Information and Computer Sciences·Andreas BenderStephan Reiling
Dec 17, 2004·Nature·Christopher M Dobson
Apr 2, 2005·Journal of Medicinal Chemistry·Dominique DouguetSylvie Pochet
Jul 13, 2005·The Journal of Experimental Medicine·Thomas RennéBernhard Nieswandt
Aug 13, 2005·Bioinformatics·Tobias SingThomas Lengauer
Aug 2, 2006·American Journal of Clinical Pathology·David T YangGeorge M Rodgers
Nov 28, 2006·Journal of Chemical Information and Modeling·S Frank YanYingyao Zhou
Dec 13, 2006·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·David J Triggle
Jul 3, 2007·British Journal of Pharmacology·D A Pereira, J A Williams
Nov 9, 2007·Journal of Computer-aided Molecular Design·John H Van Drie
Jan 16, 2010·Journal of Molecular Graphics & Modelling·Carlos Henrique Tomich de Paula da SilvaCarlton Anthony Taft
Jun 15, 2010·Journal of Medicinal Chemistry·Rafaela S FerreiraBrian K Shoichet
Oct 5, 2010·Current Opinion in Pharmacology·Jacob D Durrant, J Andrew McCammon
Nov 6, 2010·Journal of Computer-aided Molecular Design·Markus A Lill, Matthew L Danielson
Aug 4, 2011·Drug Discovery Today·Subha Kalyaanamoorthy, Yi-Ping Phoebe Chen
Sep 29, 2011·Nucleic Acids Research·Anna GaultonJohn P Overington
Nov 1, 2011·BMC Biology·Jacob D Durrant, J Andrew McCammon
Jan 28, 2012·The AAPS Journal·Tiejun ChengStephen H Bryant
Dec 21, 2012·Chemical Biology & Drug Design·William SinkoJ Andrew McCammon
Jan 16, 2013·Journal of Medicinal Chemistry·Rami A Al-HoraniUmesh R Desai
Nov 8, 2013·Nucleic Acids Research·Yanli WangStephen H Bryant
Jan 11, 2014·Journal of Medicinal Chemistry·Mimi L QuanRuth R Wexler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.